Disclosure 0001193125-26-418315-2

SEC FORM 4

—

BIOLIFE SOLUTIONS INC (BLFS)

Acquisition (code A) of 40,192 shares; price not stated (see filing).

Reporting Person Mathew Aby J. · Officer Title EVP & Chief Scientific Officer · Transaction Code A

Traded Oct 6, 2026 · Disclosed Oct 8, 2026

Source: SEC Form 4 · 0001193125-26-418315 · filed 2026-10-08 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "BIOLIFE SOLUTIONS INC (BLFS)." Disclosed 2026-10-08. https://desqlong.com/cards/0001193125-26-418315-2 (retrieved 2026-10-09).